|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 400 out of 463 for Agtr2

0.027s
Type Details Score
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3643722
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:7380550
Age: embryonic day 14.0
Note: Expression is in the undifferentiated mesenchymal cells surrounding ureter branches.
Specimen Label: 2e
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3643722
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:7380550
Age: embryonic day 14.0
Note: Expression is in the undifferentiated mesenchymal cells surrounding ureter branches.
Specimen Label: 2f
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3643724
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:7380550
Age: embryonic day 16.0
Note: Expression is in mesenchymal cells along the papillary duct, between collecting ducts, and in the undifferentiated mesenchymal cells in the region subjacent to the renal capsule.
Specimen Label: 3b
Detected: true
Specimen Num: 5
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3643724
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:7380550
Age: embryonic day 16.0
Note: Expression is in mesenchymal cells along the papillary duct, between collecting ducts, and in the undifferentiated mesenchymal cells in the region subjacent to the renal capsule.
Specimen Label: 3c
Detected: true
Specimen Num: 6
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3643724
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:7380550
Age: embryonic day 16.0
Note: Expression is in mesenchymal cells along the papillary duct, between collecting ducts, and in the undifferentiated mesenchymal cells in the region subjacent to the renal capsule.
Specimen Label: 3d
Detected: true
Specimen Num: 7
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3643726
Pattern: Regionally restricted
Stage: TS26
Assay Id: MGI:7380550
Age: embryonic day 18.0
Note: Expression is in mesenchymal cells along the papillary duct, between collecting ducts, and in the undifferentiated mesenchymal cells in the region subjacent to the renal capsule.
Specimen Label: not shown E18
Detected: true
Specimen Num: 11
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3643721
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:7382779
Age: embryonic day 13.5
Note: Expression is in undifferentiated mesenchymal cells surrounding ureter branches.
Specimen Label: not shown E13.5
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:5688686
Assay Type: RNA in situ
Annotation Date: 2015-10-01
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1741220
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:5688746
Age: embryonic day 12.5
Image: 6M
Specimen Label: 6M
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:5904267
Assay Type: Immunohistochemistry
Annotation Date: 2017-07-11
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3292728
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:5904278
Age: postnatal adult
Image: S2 islet
Specimen Label: S2 islet
Detected: true
Specimen Num: 11
GXD Expression    
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-10
Strength: Trace
Sex: Not Specified
Emaps: EMAPS:2881125
Pattern: Not Specified
Stage: TS25
Assay Id: MGI:7382779
Age: embryonic day 17.5
Specimen Label: 5f
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:4884505
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1754028
Stage: TS28
Assay Id: MGI:4944743
Age: postnatal day 7
Image: g00161 P7
Specimen Label: g00161 P7
Detected: false
Specimen Num: 3
GXD Expression      
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1764620
Stage: TS20
Assay Id: MGI:7380550
Age: embryonic day 12.0
Specimen Label: 1
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:4884505
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3280923
Stage: TS23
Assay Id: MGI:4944743
Age: embryonic day 15.5
Image: g00161 E15.5
Specimen Label: g00161 E15.5
Detected: false
Specimen Num: 2
GXD Expression
Probe: MGI:4884505
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3280928
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:4944743
Age: postnatal day 7
Image: g00161 P7
Note: Expression was region specific and scattered.
Specimen Label: g00161 P7
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:1752522
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:7380550
Age: embryonic day 14.0
Specimen Label: 2d
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1752520
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:7380550
Age: embryonic day 12.0
Specimen Label: not shown E12
Detected: true
Specimen Num: 9
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3004327
Pattern: Regionally restricted
Stage: TS27
Assay Id: MGI:7380550
Age: postnatal day 0
Note: Expression is in the medullary ray extending into the cortex.
Specimen Label: 4b
Detected: true
Specimen Num: 8
GXD Expression    
Probe: MGI:4884505
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3266523
Stage: TS23
Assay Id: MGI:4944743
Age: embryonic day 15.5
Image: g00161 E15.5
Specimen Label: g00161 E15.5
Detected: false
Specimen Num: 2
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1617725
Pattern: Regionally restricted
Stage: TS25
Assay Id: MGI:7382779
Age: embryonic day 17.5
Note: Expression is in undifferentiated mesenchymal cells around the aorta at the level where the renal artery takes off.
Specimen Label: not shown E17.5
Detected: true
Specimen Num: 6
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1617724
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:7382779
Age: embryonic day 16.0
Note: Expression is in undifferentiated mesenchymal cells around the aorta at the level where the renal artery takes off.
Specimen Label: not shown E16.0
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:4884505
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757723
Stage: TS23
Assay Id: MGI:4944743
Age: embryonic day 15.5
Image: g00161 E15.5
Specimen Label: g00161 E15.5
Detected: false
Specimen Num: 2
GXD Expression    
Probe: MGI:4884505
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757728
Stage: TS28
Assay Id: MGI:4944743
Age: postnatal day 7
Image: g00161 P7
Specimen Label: g00161 P7
Detected: false
Specimen Num: 3
GXD Expression      
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:2772122
Stage: TS22
Assay Id: MGI:7380550
Age: embryonic day 14.0
Specimen Label: 2e
Detected: false
Specimen Num: 3
GXD Expression      
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-09
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:2772122
Stage: TS22
Assay Id: MGI:7380550
Age: embryonic day 14.0
Specimen Label: 2f
Detected: false
Specimen Num: 4
GXD Expression    
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:2772121
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:7382779
Age: embryonic day 13.5
Specimen Label: not shown E13.5
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3589819
Pattern: Regionally restricted
Stage: TS19
Assay Id: MGI:7382779
Age: embryonic day 11.5
Note: Expression is around the Wolffian duct and ureteric bud.
Specimen Label: 5d
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-10
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3589825
Pattern: Regionally restricted
Stage: TS25
Assay Id: MGI:7382779
Age: embryonic day 17.5
Note: Expression is in undifferentiated mesenchymal cells surrounding the ureter.
Specimen Label: 5f
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3589821
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:7382779
Age: embryonic day 13.5
Note: Expression is in undifferentiated mesenchymal cells surrounding the ureter.
Specimen Label: not shown E13.5
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:7380543
Assay Type: RNA in situ
Annotation Date: 2022-11-10
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3589824
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:7382779
Age: embryonic day 16.0
Note: Expression is along the ureter and distributed in the surrounding undifferentiated mesenchymal cells.
Specimen Label: not shown E16.0
Detected: true
Specimen Num: 5
Publication
First Author: Okada H
Year: 2006
Journal: Am J Pathol
Title: A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.
Volume: 169
Issue: 5
Pages: 1577-89
Publication
First Author: Zuern C
Year: 2012
Journal: Int J Oncol
Title: Microtubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative disease.
Volume: 40
Issue: 4
Pages: 1079-88
Publication
First Author: Tsukuda K
Year: 2016
Journal: PLoS One
Title: Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade.
Volume: 11
Issue: 12
Pages: e0167704
Publication
First Author: Li Z
Year: 2003
Journal: Am J Physiol Heart Circ Physiol
Title: Role of AT2 receptor in the brain in regulation of blood pressure and water intake.
Volume: 284
Issue: 1
Pages: H116-21
Publication
First Author: Mizoue S
Year: 2006
Journal: Curr Eye Res
Title: Role of angiotensin II receptor subtypes in conjunctival wound healing.
Volume: 31
Issue: 2
Pages: 129-36
Publication
First Author: Isbell DC
Year: 2007
Journal: Am J Physiol Heart Circ Physiol
Title: Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling.
Volume: 293
Issue: 6
Pages: H3372-8
Publication
First Author: Abadir PM
Year: 2003
Journal: Hypertension
Title: Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice.
Volume: 42
Issue: 4
Pages: 600-4
Publication
First Author: Cervenka L
Year: 2003
Journal: J Hypertens
Title: Genetic inactivation of the B2 receptor in mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor.
Volume: 21
Issue: 8
Pages: 1531-8
Publication
First Author: Voros S
Year: 2006
Journal: Am J Physiol Heart Circ Physiol
Title: Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling.
Volume: 290
Issue: 3
Pages: H1004-10
Publication
First Author: Daugherty A
Year: 2013
Journal: PLoS One
Title: PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism.
Volume: 8
Issue: 4
Pages: e61849
Publication
First Author: Dandapat A
Year: 2008
Journal: Biochem Biophys Res Commun
Title: Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque.
Volume: 366
Issue: 4
Pages: 871-7
Publication
First Author: Robillard S
Year: 2020
Journal: Diab Vasc Dis Res
Title: Ablation of angiotensin type 2 receptor prevents endothelial nitric oxide synthase glutathionylation and nitration in ischaemic abductor muscle of diabetic mice.
Volume: 17
Issue: 1
Pages: 1479164119883978
Publication
First Author: Reinemund J
Year: 2009
Journal: Biochem Pharmacol
Title: Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes.
Volume: 77
Issue: 12
Pages: 1795-805
Publication
First Author: Sourris KC
Year: 2010
Journal: Diabetologia
Title: Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.
Volume: 53
Issue: 11
Pages: 2442-51
Publication
First Author: Yvan-Charvet L
Year: 2009
Journal: Endocrinology
Title: Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue.
Volume: 150
Issue: 3
Pages: 1421-8
Publication
First Author: Liao MC
Year: 2017
Journal: J Pathol
Title: AT2 R deficiency mediated podocyte loss via activation of ectopic hedgehog interacting protein (Hhip) gene expression.
Volume: 243
Issue: 3
Pages: 279-293
Publication
First Author: AbdAlla S
Year: 2009
Journal: J Biol Chem
Title: Dominant negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration.
Volume: 284
Issue: 10
Pages: 6566-74
Publication
First Author: Daubert DL
Year: 1999
Journal: Brain Res
Title: Changes in angiotensin II receptors in dopamine-rich regions of the mouse brain with age and ethanol consumption.
Volume: 816
Issue: 1
Pages: 8-16
Publication
First Author: Zhang SL
Year: 2004
Journal: J Am Soc Nephrol
Title: Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor.
Volume: 15
Issue: 6
Pages: 1452-65
Publication
First Author: Kakuchi J
Year: 1995
Journal: Kidney Int
Title: Developmental expression of renal angiotensin II receptor genes in the mouse.
Volume: 47
Issue: 1
Pages: 140-7
Publication
First Author: Chu KY
Year: 2010
Journal: Am J Physiol Cell Physiol
Title: Angiotensin II exerts glucose-dependent effects on Kv currents in mouse pancreatic beta-cells via angiotensin II type 2 receptors.
Volume: 298
Issue: 2
Pages: C313-23
Publication
First Author: Abadir PM
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Identification and characterization of a functional mitochondrial angiotensin system.
Volume: 108
Issue: 36
Pages: 14849-54
Publication
First Author: Wang G
Year: 2012
Journal: Am J Physiol Regul Integr Comp Physiol
Title: Angiotensin II type 2 receptor-coupled nitric oxide production modulates free radical availability and voltage-gated Ca2+ currents in NTS neurons.
Volume: 302
Issue: 9
Pages: R1076-83
Publication  
First Author: Muñoz MC
Year: 2017
Journal: Peptides
Title: Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice.
Volume: 88
Pages: 37-45
Publication
First Author: Horiuchi M
Year: 1995
Journal: J Biol Chem
Title: The growth-dependent expression of angiotensin II type 2 receptor is regulated by transcription factors interferon regulatory factor-1 and -2.
Volume: 270
Issue: 34
Pages: 20225-30
Publication
First Author: Donaldson DD
Year: 1998
Journal: J Immunol
Title: The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.
Volume: 161
Issue: 5
Pages: 2317-24
Publication
First Author: Abadir P
Year: 2018
Journal: J Invest Dermatol
Title: Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds.
Volume: 138
Issue: 2
Pages: 434-443
Publication
First Author: Akishita M
Year: 1999
Journal: Biochem Biophys Res Commun
Title: Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor.
Volume: 261
Issue: 2
Pages: 345-9
Publication
First Author: Sales VL
Year: 2005
Journal: Circulation
Title: Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution.
Volume: 112
Issue: 21
Pages: 3328-36
Publication
First Author: Iwai M
Year: 2005
Journal: Circulation
Title: Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
Volume: 112
Issue: 11
Pages: 1636-43
Publication
First Author: Ohshima K
Year: 2014
Journal: Hypertension
Title: Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
Volume: 63
Issue: 3
Pages: e53-9
Publication
First Author: Maul B
Year: 2005
Journal: FASEB J
Title: Central angiotensin II controls alcohol consumption via its AT1 receptor.
Volume: 19
Issue: 11
Pages: 1474-81
Publication
First Author: von Bohlen und Halbach O
Year: 2001
Journal: Regul Pept
Title: Genetic deletion of angiotensin AT2 receptor leads to increased cell numbers in different brain structures of mice.
Volume: 99
Issue: 2-3
Pages: 209-16
Publication
First Author: Gormally E
Year: 1998
Journal: Genet Res
Title: Faint lined (Fnl): a novel X-linked coat mutant in the mouse.
Volume: 72
Issue: 3
Pages: 211-6
Publication
First Author: Bergaya S
Year: 2004
Journal: Circ Res
Title: Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors.
Volume: 94
Issue: 12
Pages: 1623-9
Publication
First Author: Zhang MZ
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT(1) and AT(2) receptors.
Volume: 103
Issue: 43
Pages: 16045-50
Publication  
First Author: Ali Q
Year: 2016
Journal: J Renin Angiotensin Aldosterone Syst
Title: Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
Volume: 17
Issue: 3
Publication
First Author: Tanaka M
Year: 1999
Journal: Biochem Biophys Res Commun
Title: Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice.
Volume: 258
Issue: 1
Pages: 194-8
Publication
First Author: Brede M
Year: 2001
Journal: Regul Pept
Title: Transgenic mouse models of angiotensin receptor subtype function in the cardiovascular system.
Volume: 96
Issue: 3
Pages: 125-32
Publication
First Author: Castro CH
Year: 2005
Journal: Hypertension
Title: Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart.
Volume: 46
Issue: 4
Pages: 937-42
Publication
First Author: Gao J
Year: 2012
Journal: J Renin Angiotensin Aldosterone Syst
Title: Ontogeny of angiotensin type 2 and type 1 receptor expression in mice.
Volume: 13
Issue: 3
Pages: 341-52
Publication
First Author: Yu L
Year: 2014
Journal: J Renin Angiotensin Aldosterone Syst
Title: Developmental expression patterns for angiotensin receptors in mouse skin and brain.
Volume: 15
Issue: 2
Pages: 139-49
Publication
First Author: Imai Y
Year: 2005
Journal: Nature
Title: Angiotensin-converting enzyme 2 protects from severe acute lung failure.
Volume: 436
Issue: 7047
Pages: 112-6
Publication
First Author: Huang J
Year: 2013
Journal: Sci Transl Med
Title: Angiotensin-converting enzyme-induced activation of local angiotensin signaling is required for ascending aortic aneurysms in fibulin-4-deficient mice.
Volume: 5
Issue: 183
Pages: 183ra58, 1-11
Publication
First Author: D'Esposito M
Year: 1997
Journal: Hum Mol Genet
Title: Differential expression pattern of XqPAR-linked genes SYBL1 and IL9R correlates with the structure and evolution of the region.
Volume: 6
Issue: 11
Pages: 1917-23
Publication  
First Author: Callera GE
Year: 2016
Journal: Biosci Rep
Title: Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.
Volume: 36
Issue: 5
Publication
First Author: Ohinata K
Year: 2008
Journal: FEBS Lett
Title: Angiotensin II and III suppress food intake via angiotensin AT(2) receptor and prostaglandin EP(4) receptor in mice.
Volume: 582
Issue: 5
Pages: 773-7
Publication  
First Author: Chang KH
Year: 2015
Journal: Nat Commun
Title: Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial ATâ‚‚R and cytoskeletal dysregulation.
Volume: 6
Pages: 5914
Publication
First Author: Garrido-Gil P
Year: 2018
Journal: Oncotarget
Title: Aging-related dysregulation in enteric dopamine and angiotensin system interactions: implications for gastrointestinal dysfunction in the elderly.
Volume: 9
Issue: 13
Pages: 10834-10846
Publication
First Author: Gembardt F
Year: 2008
Journal: FASEB J
Title: Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors.
Volume: 22
Issue: 8
Pages: 3068-77
Publication
First Author: Walther T
Year: 2003
Journal: Regul Pept
Title: Fibrosis rather than blood pressure determines cardiac BNP expression in mice.
Volume: 116
Issue: 1-3
Pages: 95-100
Publication
First Author: van Esch JH
Year: 2010
Journal: Cardiovasc Res
Title: Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts.
Volume: 86
Issue: 3
Pages: 401-9
Publication
First Author: Lu H
Year: 2007
Journal: Am J Physiol Endocrinol Metab
Title: Angiotensin II increases adipose angiotensinogen expression.
Volume: 292
Issue: 5
Pages: E1280-7
Publication
First Author: Paquin-Veillette J
Year: 2017
Journal: Arterioscler Thromb Vasc Biol
Title: Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
Volume: 37
Issue: 12
Pages: 2291-2300
Publication
First Author: Kakinuma Y
Year: 1997
Journal: Neurosci Lett
Title: Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice.
Volume: 232
Issue: 3
Pages: 167-70
Publication
First Author: Chen YW
Year: 2008
Journal: Pediatr Nephrol
Title: Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis.
Volume: 23
Issue: 10
Pages: 1769-77
Publication
First Author: Wang N
Year: 2012
Journal: PLoS One
Title: Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
Volume: 7
Issue: 4
Pages: e35632
Publication
First Author: Habashi JP
Year: 2011
Journal: Science
Title: Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.
Volume: 332
Issue: 6027
Pages: 361-5
Publication
First Author: Herradon G
Year: 2004
Journal: Biochem Biophys Res Commun
Title: Pleiotrophin is an important regulator of the renin-angiotensin system in mouse aorta.
Volume: 324
Issue: 3
Pages: 1041-7
Publication
First Author: AbdAlla S
Year: 2009
Journal: J Biol Chem
Title: Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease.
Volume: 284
Issue: 10
Pages: 6554-65
Publication
First Author: Iosipiv IV
Year: 2003
Journal: Am J Physiol Renal Physiol
Title: A role for angiotensin II AT1 receptors in ureteric bud cell branching.
Volume: 285
Issue: 2
Pages: F199-207
Publication
First Author: Sutton KA
Year: 1997
Journal: Genomics
Title: The rapidly evolving Pem homeobox gene and Agtr2, Ant2, and Lamp2 are closely linked in the proximal region of the mouse X chromosome.
Volume: 45
Issue: 2
Pages: 447-50
Publication
First Author: Mitsuishi M
Year: 2009
Journal: Diabetes
Title: Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control.
Volume: 58
Issue: 3
Pages: 710-7
Publication
First Author: Potter AS
Year: 2015
Journal: PLoS One
Title: Molecular Anatomy of Palate Development.
Volume: 10
Issue: 7
Pages: e0132662
Publication
First Author: Matsushita K
Year: 2016
Journal: Lab Invest
Title: Deletion of angiotensin II type 2 receptor accelerates adipogenesis in murine mesenchymal stem cells via Wnt10b/beta-catenin signaling.
Volume: 96
Issue: 8
Pages: 909-17
Publication
First Author: Taguchi K
Year: 2012
Journal: Pharmacol Res
Title: Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db/db mice is mediated via a MEK pathway.
Volume: 66
Issue: 1
Pages: 41-50
Publication
First Author: Takasaki N
Year: 2000
Journal: Dev Biol
Title: Gpbox (Psx2), a homeobox gene preferentially expressed in female germ cells at the onset of sexual dimorphism in mice.
Volume: 223
Issue: 1
Pages: 181-93
Publication
First Author: Machura K
Year: 2009
Journal: Am J Physiol Renal Physiol
Title: Developmental renin expression in mice with a defective renin-angiotensin system.
Volume: 297
Issue: 5
Pages: F1371-80
Publication
First Author: Oudit GY
Year: 2003
Journal: Trends Cardiovasc Med
Title: The role of ACE2 in cardiovascular physiology.
Volume: 13
Issue: 3
Pages: 93-101
Publication
First Author: Matsusaka T
Year: 1997
Journal: Semin Nephrol
Title: Targeting the genes of angiotensin receptors.
Volume: 17
Issue: 5
Pages: 396-403
Publication
First Author: Perlegas D
Year: 2005
Journal: Am J Physiol Heart Circ Physiol
Title: ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development.
Volume: 288
Issue: 1
Pages: H96-102